source
- Flagship launches UK lab to build AI-driven biotechs with £100M investmentFlagship Pioneering, the life science investor behind the likes of Moderna, has launched a new lab in London focused on building “AI-native platform companies” in the UK. The announcement marks Fla…Endpoints · 1h ago↗ source
- FDA denies Summit Therapeutics' ivonescimab for EGFR-mutated lung cancer, halting US entryThe U.S. Food and Drug Administration issued a complete response letter rejecting Summit Therapeutics' biologics license application for ivonescimab, a PD-1xVEGF bispecific antibody intended for EG…